| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Single-Center Experience With Brentuximab Vedotin in Gamma Delta T-Cell Lymphoma
|
Talpur, Rakhshandra
|
|
2016
|
16 |
2 |
p. e15-e19
nvt p.
|
artikel
|
| 2 |
Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions
|
Mathur, Pankaj
|
|
2016
|
16 |
2 |
p. 70-75
6 p.
|
artikel
|
| 3 |
Clinical Characteristics and Treatment Outcome of Chinese Patients With Systemic Amyloid Light-Chain Amyloidosis: A Retrospective Single-Center Analysis
|
Zhao, Qian
|
|
2016
|
16 |
2 |
p. 104-110
7 p.
|
artikel
|
| 4 |
Diagnosis and Treatment of Chronic Myeloid Leukemia in the Imatinib Mesylate Era: Report of the Experience at “La Raza” Medical Center in Mexico
|
Ayala, Manuel
|
|
2016
|
16 |
2 |
p. 57-62
6 p.
|
artikel
|
| 5 |
Donor Lymphocyte Infusion in Hematologic Malignancies—Good to be Fresh?
|
Hossain, Nasheed Mohammad
|
|
2016
|
16 |
2 |
p. 111-115
5 p.
|
artikel
|
| 6 |
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma
|
Lamar, Zanetta S.
|
|
2016
|
16 |
2 |
p. 76-81
6 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2016
|
16 |
2 |
p. A2-
1 p.
|
artikel
|
| 8 |
Ibrutinib as a Bruton Kinase Inhibitor in the Management of Chronic Lymphocytic Leukemia: A New Agent With Great Promise
|
Foluso, Ogunleye
|
|
2016
|
16 |
2 |
p. 63-69
7 p.
|
artikel
|
| 9 |
Predictive Value of Glycated Hemoglobin and Body Mass Index for Pretreatment Neuropathy in Patients With Multiple Myeloma
|
Lakshman, Arjun
|
|
2016
|
16 |
2 |
p. 89-95
7 p.
|
artikel
|
| 10 |
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia
|
Giaccone, Luisa
|
|
2016
|
16 |
2 |
p. 96-103
8 p.
|
artikel
|
| 11 |
Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients With Hepatic Impairment
|
Gupta, Arjun
|
|
2016
|
16 |
2 |
p. e11-e14
nvt p.
|
artikel
|
| 12 |
Table of Contents
|
|
|
2016
|
16 |
2 |
p. A4-
1 p.
|
artikel
|
| 13 |
90Y-Ibritumomab-Tiuxetan Consolidation Therapy for Advanced-Stage Mantle Cell Lymphoma After First-Line Autologous Stem Cell Transplantation: Is It Time for a Step Forward?
|
Mondello, Patrizia
|
|
2016
|
16 |
2 |
p. 82-88
7 p.
|
artikel
|
Tijdschrift beschrijving